ES529593A0 - Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona - Google Patents

Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona

Info

Publication number
ES529593A0
ES529593A0 ES529593A ES529593A ES529593A0 ES 529593 A0 ES529593 A0 ES 529593A0 ES 529593 A ES529593 A ES 529593A ES 529593 A ES529593 A ES 529593A ES 529593 A0 ES529593 A0 ES 529593A0
Authority
ES
Spain
Prior art keywords
derivatives
benzazoninone
benzazocinone
procedure
preparing new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529593A
Other languages
English (en)
Other versions
ES8606286A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8606286A1 publication Critical patent/ES8606286A1/es
Publication of ES529593A0 publication Critical patent/ES529593A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES529593A 1983-02-10 1984-02-09 Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona Expired ES8606286A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/465,696 US4470988A (en) 1983-02-10 1983-02-10 Benzazocinone and benzazoninone derivatives, and their pharmaceutical use

Publications (2)

Publication Number Publication Date
ES8606286A1 ES8606286A1 (es) 1986-04-01
ES529593A0 true ES529593A0 (es) 1986-04-01

Family

ID=23848809

Family Applications (2)

Application Number Title Priority Date Filing Date
ES529593A Expired ES8606286A1 (es) 1983-02-10 1984-02-09 Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona
ES544051A Expired ES8700240A1 (es) 1983-02-10 1985-06-11 Procedimiento para preparar nuevos derivados de benzazocino-na y de benzaconinona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES544051A Expired ES8700240A1 (es) 1983-02-10 1985-06-11 Procedimiento para preparar nuevos derivados de benzazocino-na y de benzaconinona

Country Status (20)

Country Link
US (1) US4470988A (es)
EP (1) EP0119161B1 (es)
JP (1) JPS59172474A (es)
KR (1) KR840007872A (es)
AT (1) ATE44279T1 (es)
AU (1) AU2443184A (es)
CA (1) CA1218989A (es)
DD (1) DD216717A5 (es)
DE (1) DE3478810D1 (es)
DK (1) DK58084A (es)
ES (2) ES8606286A1 (es)
FI (1) FI840463A7 (es)
GR (1) GR81766B (es)
HU (1) HU193671B (es)
IE (1) IE56816B1 (es)
IL (1) IL70882A0 (es)
NO (1) NO840486L (es)
NZ (1) NZ207090A (es)
PT (1) PT78064B (es)
ZA (1) ZA84959B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873235A (en) * 1982-06-01 1989-10-10 Merck & Co., Inc. Benzofused lactams as antihypertensives
US4537885A (en) * 1983-02-10 1985-08-27 Ciba Geigy Corporation Certain benzazocinone and benzazoninone derivatives
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5145864A (en) * 1987-09-15 1992-09-08 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
RU2124503C1 (ru) 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
AU681924B2 (en) * 1993-11-22 1997-09-11 Merck & Co., Inc. 3-acylaminobenzazepines
SK282019B6 (sk) * 1994-08-18 2001-10-08 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluóretyl)-2-oxo-5-fenyl-1h-1,4- benzodiazepínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
WO1996040656A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
WO2011110277A1 (en) 2010-03-11 2011-09-15 Merck Patent Gmbh Fibers in therapy and cosmetics
CN118748991A (zh) * 2022-03-23 2024-10-08 浙江华海药业股份有限公司 一种纯化左乙拉西坦中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1191963A (en) * 1968-02-07 1970-05-13 Ucb Sa Heterocyclic Compounds
GB1183442A (es) * 1968-02-23 1970-03-04
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel
GR74635B (es) * 1980-08-18 1984-06-29 Merck & Co Inc
IL63540A0 (en) * 1980-08-18 1981-11-30 Merck & Co Inc Substituted enantholactam derivatives as antihypertensives
PT73522B (en) * 1980-08-18 1983-07-14 Merck & Co Inc Process for preparing substituted caprylolactam derivatives as antihypertensives
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
EP0107095B1 (en) * 1982-09-30 1987-09-09 Merck & Co. Inc. 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents

Also Published As

Publication number Publication date
IE840301L (en) 1984-08-10
ES8606286A1 (es) 1986-04-01
CA1218989A (en) 1987-03-10
DK58084D0 (da) 1984-02-09
IE56816B1 (en) 1991-12-18
GR81766B (es) 1984-12-12
KR840007872A (ko) 1984-12-11
DK58084A (da) 1984-08-11
EP0119161A2 (de) 1984-09-19
FI840463A7 (fi) 1984-08-11
IL70882A0 (en) 1984-05-31
ES8700240A1 (es) 1986-09-16
PT78064B (en) 1986-06-02
FI840463A0 (fi) 1984-02-06
AU2443184A (en) 1984-08-16
DD216717A5 (de) 1984-12-19
NO840486L (no) 1984-08-13
EP0119161B1 (de) 1989-06-28
NZ207090A (en) 1985-10-11
ZA84959B (en) 1984-09-26
ES544051A0 (es) 1986-09-16
JPH0449545B2 (es) 1992-08-11
JPS59172474A (ja) 1984-09-29
PT78064A (en) 1984-03-01
ATE44279T1 (de) 1989-07-15
EP0119161A3 (en) 1986-06-11
DE3478810D1 (en) 1989-08-03
HU193671B (en) 1987-11-30
US4470988A (en) 1984-09-11

Similar Documents

Publication Publication Date Title
ES529593A0 (es) Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
SE8503680D0 (sv) Indolderivat
DE69824029D1 (de) Bicyclische kinase inhibitoren
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
AP9901478A0 (en) Compounds for the treatment of ischemia.
DK163145C (da) Analogifremgangsmaade til fremstilling af 6-substituerede s-triazoloe3,4-aaaftalazin-derivater
DK0922045T3 (da) Bicykliske pyrimidinderivater og deres anvendelse som antikoagulanter
DK0813525T3 (da) Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
UA39166C2 (uk) Похідні n-гідроксисечовини, що є інгібіторами ліпоксигенази у ссавців, спосіб їх одержання і спосіб інгібування ліпоксигенази у ссавців
AR024138A1 (es) Inhibidores de la proliferacion celular
BR9811099A (pt) Inibidores de urocinase
GR900100326A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
DK229187A (da) 1-substituerede imidazolderivater, 2-thion-tautomere og ikke-toksiske, farmaceutisk acceptable salte deraf
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
BG45552A3 (bg) Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler
SE9604582D0 (sv) Novel compounds
NO821841L (no) Mettede aminocyklitderivater, deres fremstilling og legemiddel inneholdende dem
IL70342A0 (en) Compounds for treating hypertension,processes for the preparation thereof and pharmaceutical compositions containing them
SE9603726D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401